Currently, the use of cytokines from the IL-2 family (also known as the common gamma chain cytokine family) including IL-2, IL-15 and IL-21 to activate the immune systems of tumor patients becomes one of the most important fields in tumor immunotherapy research 41. Here, IL21 is linked to neoplasm.